ArticleJournal of acquired immune deficiency syndromes (1999)2025

Identifying preferred program delivery attributes for long-acting injectable cabotegravir-rilpvirine in three U.S. HIV clinics: A discrete choice experiment.

Jose I Gutierrez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.